Nanoparticle-Mediated Drug Delivery: Enhancing Therapeutic Efficacy and Minimizing Toxicity

This research focuses on developing innovative nanoparticle-based drug delivery systems to enhance therapeutic efficacy while minimizing adverse effects. We engineered biocompatible polymeric nanoparticles capable of encapsulating various therapeutic agents, demonstrating improved stability, prolonged circulation times, and preferential accumulation in target tissues. Surface functionalization with targeting ligands achieved unprecedented specificity in drug delivery. Our nanoparticle formulations exhibited superior tumor accumulation in preclinical cancer models, enhancing therapeutic efficacy and reducing systemic toxicity. Additionally, we developed stimuli-responsive nanoparticles for precise spatiotemporal control over drug release. These advanced delivery systems promise to improve patient outcomes and advance personalized nanomedicine.

Authors

Institutions

Publication Details

Published
2025-10-02
DOI
https://doi.org/10.3390/engproc2025109019
Citations
1
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nanoparticle-Mediated Drug Delivery: Enhancing Therapeutic Efficacy and Minimizing Toxicity

Amos M. Mwaura, Andrew Waititu, Tabitha Waithira
1 citations
Nanoplatforms for cancer theranostics
0.67
article

Nanoparticle-Mediated Drug Delivery: Enhancing Therapeutic Efficacy and Minimizing Toxicity

Amos M. Mwaura, Andrew Waititu, Tabitha Waithira
article en
1 citations

Abstract

This research focuses on developing innovative nanoparticle-based drug delivery systems to enhance therapeutic efficacy while minimizing adverse effects. We engineered biocompatible polymeric nanoparticles capable of encapsulating various therapeutic agents, demonstrating improved stability, prolonged circulation times, and preferential accumulation in target tissues. Surface functionalization with targeting ligands achieved unprecedented specificity in drug delivery. Our nanoparticle formulations exhibited superior tumor accumulation in preclinical cancer models, enhancing therapeutic efficacy and reducing systemic toxicity. Additionally, we developed stimuli-responsive nanoparticles for precise spatiotemporal control over drug release. These advanced delivery systems promise to improve patient outcomes and advance personalized nanomedicine.

Kenyatta University (KE), Tallaght University Hospital (IE), Child Welfare Society of Kenya (KE)
Openalex Percentile: Top 26%
Nanoplatforms for cancer theranostics
0.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.